ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,794 companies indexed · Last updated: today
DirectoryFinance & InsuranceHolding CompaniesGenevaNeurosterix Swiss Holdings AG
Neurosterix Swiss Holdings AG Logo
Verified· 2 sources

Neurosterix Swiss Holdings AG

Summary

About the company

Neurosterix Swiss Holdings AG develops allosteric modulators to design targeted therapies for complex neuropsychiatric disorders. The company uses a proprietary discovery platform to identify selective positive and negative allosteric modulators and advances clinical and preclinical programs, including M4 PAM and mGlu7 NAM candidates for indications such as psychosis, mood, and anxiety disorders.

AI-generated
Offering

Products & services

Industry:Holding Companies
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Development of allosteric modulators
Development of novel allosteric modulators for neuropsychiatric diseases, focusing on psychotic, affective and anxiety disorders.
CNS therapy pipeline development
Pipeline with preclinical and clinical programs, including NTX-253, NTX-529 and NTX-819 for schizophrenia, psychosis, mood and anxiety disorders.
CNS research and drug discovery
Discovery engine with 80,000+ compounds, 200+ functional CNS assays, and screening campaigns to identify new drug candidates.
Translational science
Translating receptor pharmacology and preclinical data into clinical candidates, focusing on neuropsychiatric target structures and development readiness.
Clinical development
Planning and conducting clinical studies for novel neuropsychiatric therapeutics, including Phase 1 studies and further clinical development steps.

Knowledge

No knowledge articles yet

Once Neurosterix Swiss Holdings AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Neurosterix Swiss Holdings AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Neurosterix Swiss Holdings AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Neurosterix Swiss Holdings AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Chemin des Mines 9
1202 Geneva

At a glance

Legal form
Corporation
UID
CHE-235.919.086
Founded
2024 · 2 years
Last commercial register change
May 4, 2026
Employees
21 to 50

Similar companies

MT
MindMaze Therapeutics Holding SA
Geneva
CB
Campus Biotech Sàrl
Geneva
BG
Buxum Group Holding SA
Geneva
WI
WISeKey International Holding AG (WISeKey International Holding SA) (WISeKey International Holding Ltd), succursale de Meyrin
Cointrin
SG
Symbiotics Group SA
Geneva
GH
group8 holding Sàrl
Carouge Ge
CH
Canonica Holding SA
Vernier
BH
Bordier Holdings SA
Geneva